Biofrontera Inc (BFRI)

Name: Biofrontera Inc (BFRI) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Biofrontera Inc (BFRI)

Stock Card

$1.57

$0.08 (5.37%)

As on 28-Aug-2026 13:36EDT

Market cap

$22 Mln

Revenue (TTM)

$46 Mln

P/E Ratio

P/B Ratio

3.7

Div. Yield

0 %

Biofrontera Inc (BFRI) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.51 High: 1.61

52 Week Range

Low: 0.55 High: 1.61

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-9.9 %
ROCE

-- %
Industry P/E

37.31
EV/EBITDA

-0.8
Debt to Equity

0
Book Value

$--
EPS

$-0.6
Face value

--
Shares outstanding

14,852,359

5 Years Aggregate

CFO

$-117.86 Mln

EBITDA

$-81.87 Mln

Net Profit

$-80.45 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Biofrontera Inc (BFRI)	175.4	49.5	83.0	82.6	-43.5	--	--
BSE Sensex	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022
Biofrontera Inc (BFRI)	-47.7	-60.3	-84.9	-87.8
S&P Small-Cap 600	4.0	7.0	13.9	-17.4
BSE Sensex	9.1	8.1	18.7	4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Biofrontera Inc (BFRI)	1.6	22.0	46.2	-6.4	-12.2	-77.5	--	3.7
Amneal Pharmaceuticals Inc Class A (AMRX)	17.6	6,238.0	3,117.6	157.4	14.7	--	37.3	188.9
Axsome Therapeutics (AXSM)	200.5	10,883.2	776.6	-191.6	-17.6	-223.4	--	130.9
BridgeBio Pharma (BBIO)	77.1	15,932.7	691.8	-696.2	-89.1	--	--	123.7
Corcept Therapeutics (CORT)	113.8	13,215.0	830.8	54.9	3.2	8.1	271.7	18.7
Elanco Animal Health (ELAN)	24.1	11,971.8	5,020.0	-199.0	1.6	-3	--	1.8
Grifols S.A. - ADR	7.8	5,444.6	7,430.4	452.5	17.6	7	10.4	0.8
Ligand Pharmaceuticals (LGND)	279.9	5,707.4	290.5	197.2	82.5	19.9	29.6	5.9
Liquidia Technologies Inc (LQDA)	68.5	6,142.1	450.9	138.6	39.1	115.6	49	31.5
Twist Bioscience Corp (TWST)	143.8	9,129.6	431.8	-136.7	-30.8	-30.3	--	20.5

Shareholding Pattern

View Details

About Biofrontera Inc (BFRI)

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED... Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. Read more

CEO, President & Executive Chairman

Dr. Hermann Luebbert Ph.D.
CEO, President & Executive Chairman

Dr. Hermann Luebbert Ph.D.
Headquarters

Woburn, MA
Website

https://www.biofrontera-us.com

FAQs for Biofrontera Inc (BFRI)

What is the current share price of Biofrontera Inc (BFRI) Today?

The share price of Biofrontera Inc (BFRI) is $1.57 (NASDAQ) as of 28-Aug-2026 13:36 EDT. Biofrontera Inc (BFRI) has given a return of -43.53% in the last 3 years.

What is the current PB & PE ratio of Biofrontera Inc (BFRI)?

Since, TTM earnings of Biofrontera Inc (BFRI) is negative, P/E ratio is not available.
The P/B ratio of Biofrontera Inc (BFRI) is 3.69 times as on 21-Aug-2026, a 52 discount to its peers’ median range of 7.75 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-0.63	0.63
2024	-0.34	1.36
2023	-0.29	1.24
2022	-1.91	0.05
2021	-68.21	226.90

What is the 52 Week High and Low of Biofrontera Inc (BFRI)?

The 52-week high and low of Biofrontera Inc (BFRI) are Rs 1.61 and Rs 0.55 as of 29-Aug-2026.

What is the market cap of Biofrontera Inc (BFRI)?

Biofrontera Inc (BFRI) has a market capitalisation of $ 22 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Biofrontera Inc (BFRI)?

Before investing in Biofrontera Inc (BFRI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.